LCLeslie J. Crofford

Leslie J. Crofford

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leslie J. Crofford has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Fumiaki Kojima

    Department of Internal Medicine, Division of Rheumatology, Kentucky Clinic University of Kentucky Lexington Kentucky USA

    1 shared publication
  • Lihua Yang

    Department of Internal Medicine, Division of Rheumatology, Kentucky Clinic University of Kentucky Lexington Kentucky USA

    1 shared publication
  • Min Qian

    Ophthalmology and Visual Sciences, Cell and Developmental Biology University of Michigan Medical School Ann Arbor Michigan USA

    1 shared publication
  • Mohit Kapoor

    Department of Internal Medicine, Rheumatology Division, Kentucky Clinic, University of Kentucky, Lexington, KY 40536-0284, USA

    1 shared publication

Latest Publications

  • Open Access

    Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase‐1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis

    by Mohit Kapoor, Fumiaki Kojima, Min Qian, Lihua Yang, Leslie J. Crofford

    Microsomal postaglandin (PG) E synthase (mPGES)‐1 is an inducible enzyme that acts downstream of cyclooxygenase (COX) and specifically catalyzes the conversion of prostaglandin (PG)H 2 to PGE 2 , most prominently in inflammatory conditions. Specific inhibitors of mPGES‐1 are not yet available, however, mice with genetic deletion of mPGES‐1 have been generated that have given insight into the specific role of mPGES‐1 in eicosanoid biosynthesis in vivo and in peritoneal macrophages. We created mouse embryo fibroblast (MEF) cell lines that would facilitate investigation of the effect of mPGES‐1 genetic deletion on prostanoid biosynthesis in fibroblast lineage cells and its subsequent effect on the expression of inducible NOS (iNOS) and nitrite biosynthesis using cells derived from mPGES‐1 wild‐type (WT), heterozygous (Het), and null mice. The results show that genetic deletion of mPGES‐1 results in a dramatic decrease in PGE 2 production in Het and null MEFs under basal conditions and after stimulation with interleukin (IL)‐1β, suggesting that mPGES‐1 is critically important for PGE 2 production. Furthermore, we show that mPGES‐1 gene deletion results in diversion of prostanoid production from PGE 2 to 6‐keto PGF 1 α (the stable metabolic product of PGI 2 ; prostacyclin) in a gene dose‐dependent manner in Het and null MEFs compared with their WT counterparts, suggesting a shunting phenomenon within the arachidonic acid (AA) metabolic pathway. In addition, we show that mPGES‐1 gene deletion and subsequent decrease in PGE 2 levels results in a differential induction profile of iNOS and nitrite levels (the stable breakdown product of nitric oxide (NO) in mPGES‐1 WT MEFs compared with null MEFs. These results provide important information regarding the therapeutic potential for pharmacologic inhibition of mPGES‐1 in inflammatory conditions.—Kapoor, M., Kojima, F., Qian, M., Yang, L., and Crofford, L. J. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase‐1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. FASEB J. 20, E1704 –E1715 (2006)